Back
Range Cancer Therapeutics ETF Stock Price Chart
Today's Fastest Growing Company Might Surprise You
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
36
CNCR
Range Cancer Therapeutics ETF
Last Price:
$12.95
Seasonality Move:
-2.04%
7 Day Trial
ALL ACCESS PASS
$
7
Hidden Stock Under $5 Holds Tech World Hostage
Click here to see more.-
The current trend is relatively stagnant and CNCR is experiencing slight selling pressure.
Range Cancer Therapeutics ETF Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.33 | Buy |
| 20-day SMA: | 13.08 | Sell |
| 50-day SMA: | 14 | Sell |
| 200-day SMA: | 14.65 | Sell |
| 8-day EMA: | 12.5 | Buy |
| 20-day EMA: | 12.93 | Sell |
| 50-day EMA: | 13.66 | Sell |
| 200-day EMA: | 14.26 | Sell |
Range Cancer Therapeutics ETF Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.49 | Sell |
| Relative Strength Index (14 RSI): | 41.98 | Sell |
| Chaikin Money Flow: | -540 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (12.46 - 14.04) | Sell |
| Bollinger Bands (100): | (13.46 - 15.38) | Sell |
Range Cancer Therapeutics ETF Technical Analysis
| Dec 16 | Dec 17 | Dec 18 | Dec 20 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 16 | 17 | 18 | 20 | 24 | 26 | 27 | 30 | 31 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Range Cancer Therapeutics ETF Stock
Is Range Cancer Therapeutics ETF Stock a Buy?
-
Range Cancer Therapeutics ETF share price is 12.60 while CNCR 8-day simple moving average is 12.33, which is a Buy signal.
-
The stock price of CNCR is 12.60 while Range Cancer Therapeutics ETF 20-day SMA is 13.08, which makes it a Sell.
-
Range Cancer Therapeutics ETF 50-day simple moving average is 14.00 while CNCR share price is 12.60, making it a Sell technically.
-
CNCR stock price is 12.60 and Range Cancer Therapeutics ETF 200-day simple moving average is 14.65, creating a Sell signal.
CNCR Technical Analysis vs Fundamental Analysis
Sell
36
Range Cancer Therapeutics ETF (CNCR)
is a Sell
Is Range Cancer Therapeutics ETF a Buy or a Sell?
-
Range Cancer Therapeutics ETF stock is rated a SellThe current Range Cancer Therapeutics ETF [CNCR] share price is $12.60. The Score for CNCR is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
Range Cancer Therapeutics ETF Stock Info
Market Cap:
0
Price in USD:
12.60
Share Volume:
2.6K
Range Cancer Therapeutics ETF 52-Week Range
52-Week High:
17.96
52-Week Low:
11.87
Sell
36
Range Cancer Therapeutics ETF (CNCR)
is a Sell
Range Cancer Therapeutics ETF Share Price Forecast
-
What is the Range Cancer Therapeutics ETF stock price today?The Range Cancer Therapeutics ETF stock price is 12.60 USD today.
-
Will CNCR stock go up or go down?Range Cancer Therapeutics ETF> share price is forecast to RISE/FALL based on technical indicators
-
Is Range Cancer Therapeutics ETF overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Range Cancer Therapeutics ETF is overvalued.
Is Range Cancer Therapeutics ETF Stock a Buy?
-
Range Cancer Therapeutics ETF share price is 12.60 while CNCR 8-day exponential moving average is 12.50, which is a Buy signal.
-
The stock price of CNCR is 12.60 while Range Cancer Therapeutics ETF 20-day EMA is 12.93, which makes it a Sell.
-
Range Cancer Therapeutics ETF 50-day exponential moving average is 13.66 while CNCR share price is 12.60, making it a Sell technically.
-
CNCR stock price is 12.60 and Range Cancer Therapeutics ETF 200-day simple moving average is 14.26, creating a Sell signal.
Technical Analysis of Range Cancer Therapeutics ETF
Should I short Range Cancer Therapeutics ETF stock?
-
CNCR Moving Average Covergence Divergence (MACD) indicator is -0.49, suggesting Range Cancer Therapeutics ETF is a Sell
-
Range Cancer Therapeutics ETF Relative Strength Index (RSI) is 41.98, which suggest Range Cancer Therapeutics ETF is oversold
-
The Bollinger Bands (25) for Range Cancer Therapeutics ETF is (12.46 - 14.04), which suggest Range Cancer Therapeutics ETF is a Sell
-
The Bollinger Bands (100) for Range Cancer Therapeutics ETF is (13.46 - 15.38), which suggest Range Cancer Therapeutics ETF is a Sell
* Range Cancer Therapeutics ETF stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.